New Life Sciences Corridor Links Abu Dhabi and California Health Innovators
全新生命科學廊道連結阿布達比與加州健康創新者
更新於: 2026年6月24日 下午12:30
In June 2026, a groundbreaking partnership was announced that promises to reshape global healthcare: the New Life Sciences Corridor.
2026年6月，一項預計將重塑全球醫療保健的開創性合作夥伴關係宣告成立：新生命科學走廊。
This strategic link connects California—a world-leading hub for innovation—with Abu Dhabi’s rapidly evolving healthcare ecosystem.
這條戰略紐帶將世界領先的創新中心——加利福尼亞州，與阿布達比發展迅速的醫療保健生態系統連接起來。
By joining the efforts of the Department of Health – Abu Dhabi (DoH) and Biocom California, this initiative acts as a formal gateway for researchers, investors, and entrepreneurs to collaborate across borders.
透過結合阿布達比衛生部(DoH)與加州生物醫學工業協會(Biocom California)的努力，該倡議成為研究人員、投資者與企業家跨國合作的正式門戶。
A key feature of this corridor is the 'Living Lab' model, which offers US-based biotech and medical technology firms unique access to Abu Dhabi’s intelligent healthcare infrastructure.
該走廊的一個關鍵特色是「生活實驗室」模式，它為美國的生物技術與醫療科技公司提供了進入阿布達比智慧醫療基礎設施的獨特機會。
This setup allows companies to test, validate, and implement new health technologies in a real-world, integrated environment.
這種架構讓各公司能夠在現實世界、整合性的環境中測試、驗證並實施新的醫療技術。
Beyond shared resources, the partnership focuses on knowledge exchange, with both regions committed to sharing best practices in policy and cluster development.
除了共享資源外，該夥伴關係還聚焦於知識交流，雙方皆致力於分享政策與產業群聚發展的最佳實踐。
Unveiled at the BIO International Convention 2026, the corridor underscores a global shift toward borderless innovation.
該走廊在2026年生物國際大會(BIO International Convention)上揭幕，突顯了全球朝向無國界創新的趨勢。
By bridging California’s vast life sciences network with Abu Dhabi’s commitment to fields like AI-enabled medicine and genomics, the initiative ensures that scientific discoveries can move from the laboratory to patient care faster than ever before.
藉由將加州廣大的生命科學網絡與阿布達比對人工智慧醫療與基因組學等領域的投入相結合，該倡議確保了科學發現能比以往更快地從實驗室邁向患者護理。
